Caricamento...
Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting
INTRODUCTION: Long-acting injectable (LAI) antipsychotics were developed to increase medication adherence in patients with schizophrenia. The US Food and Drug Administration (FDA)-approved LAI dosing provides guidance regarding oral antipsychotic supplementation. Previous studies have concluded conc...
Salvato in:
| Pubblicato in: | Ment Health Clin |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
College of Psychiatric & Neurologic Pharmacists
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322819/ https://ncbi.nlm.nih.gov/pubmed/30627499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2019.01.018 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|